VANGUARD GROUP INC - HEPION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,570,355
+158.6%
3,310,1800.0%0.00%
Q4 2022$994,047
-40.5%
3,310,180
+0.1%
0.00%
Q3 2022$1,672,000
-11.7%
3,308,5230.0%0.00%
Q2 2022$1,894,000
-55.6%
3,308,5230.0%0.00%
Q1 2022$4,268,000
+12.6%
3,308,523
-0.5%
0.00%
Q4 2021$3,792,000
-25.6%
3,326,017
-0.1%
0.00%
Q3 2021$5,096,000
-22.7%
3,330,7410.0%0.00%
Q2 2021$6,595,000
+7.6%
3,330,741
-0.0%
0.00%
Q1 2021$6,129,000
+61.9%
3,331,196
+92.7%
0.00%
Q4 2020$3,786,0001,728,6040.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 923,230$2,022,0000.82%
Worth Venture Partners, LLC 233,947$512,0000.40%
PERKINS CAPITAL MANAGEMENT INC 150,000$329,0000.22%
GSA CAPITAL PARTNERS LLP 89,067$195,0000.03%
PREMIER ASSET MANAGEMENT LLC 70,000$153,0000.03%
Allen Capital Group, LLC 23,685$52,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$110,0000.01%
Prospera Financial Services Inc 39,300$86,0000.01%
Onex Canada Asset Management Inc. 20,000$44,0000.00%
Schonfeld Strategic Advisors LLC 95,300$208,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders